A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up
Introduction. Systemic lupus erythematosus (SLE) is a chronic immunological disease causing a significant morbidity and mortality in younger women and involving several organs and systems, most often the kidneys, being consequently the incidence of lupus nephritis (LN) about 60%. Case report. We...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Military Health Department, Ministry of Defance, Serbia
2011-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501108705J.pdf |
| _version_ | 1819292189714284544 |
|---|---|
| author | Jovanović Nataša Marković-Lipkovski Jasmina Pavlović Stevan Stojimirović Biljana |
| author_facet | Jovanović Nataša Marković-Lipkovski Jasmina Pavlović Stevan Stojimirović Biljana |
| author_sort | Jovanović Nataša |
| collection | DOAJ |
| description | Introduction. Systemic lupus erythematosus (SLE) is a chronic immunological disease causing a significant morbidity and mortality in younger women and involving several organs and systems, most often the kidneys, being consequently the incidence of lupus nephritis (LN) about 60%. Case report. We reported a 57 year-old patient with the diagnosed SLE in 1995. Pathohistological analysis of kidney biopsy revealed LN type V. The patient was treated with corticosteroid pulses and azathioprine during one year. A remission was achieved and maintained with prednisone, 15 mg daily. Nephrotic relapse was diagnosed in 2006 and the second kidney biopsy revealed recent kidney infarction due to extensive vasculitis. Soon, a cerebrovascul insult developed and CT-scan revealed endocranial infarctus. The patient was treated with corticosteroids and cyclophosphamide pulses (totally VI monthly pulses), and also with low-molecular heparine, anticoagulants and salicylates because of the right leg phlebothrombosis. After the pulses, the patient was adviced to take prednisone 20 mg daily and azothioprine 100 mg daily, and 6 months later mycophenolate mofetil because of persistent active serological immunological findings (ANA 1 : 320) and nephrotic syndrome. Mycophenolate mofetil was efficient in inducing and maintaining remission of nephrotic syndrome. Conclusion. The aim of LN treatment is to achieve and maintain remission, improve patients’ outcome, reduce the toxicity of immunosuppressive drugs and the incidence of relapses. Mycophenolate mofetil was shown to be efficient in inducing and maintaining remission of nephrotic syndrome in the frame of LN. |
| first_indexed | 2024-12-24T03:50:35Z |
| format | Article |
| id | doaj.art-46e538b8f75c4addbde082e421d04b31 |
| institution | Directory Open Access Journal |
| issn | 0042-8450 |
| language | English |
| last_indexed | 2024-12-24T03:50:35Z |
| publishDate | 2011-01-01 |
| publisher | Military Health Department, Ministry of Defance, Serbia |
| record_format | Article |
| series | Vojnosanitetski Pregled |
| spelling | doaj.art-46e538b8f75c4addbde082e421d04b312022-12-21T17:16:35ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502011-01-0168870570810.2298/VSP1108705JA patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-upJovanović NatašaMarković-Lipkovski JasminaPavlović StevanStojimirović BiljanaIntroduction. Systemic lupus erythematosus (SLE) is a chronic immunological disease causing a significant morbidity and mortality in younger women and involving several organs and systems, most often the kidneys, being consequently the incidence of lupus nephritis (LN) about 60%. Case report. We reported a 57 year-old patient with the diagnosed SLE in 1995. Pathohistological analysis of kidney biopsy revealed LN type V. The patient was treated with corticosteroid pulses and azathioprine during one year. A remission was achieved and maintained with prednisone, 15 mg daily. Nephrotic relapse was diagnosed in 2006 and the second kidney biopsy revealed recent kidney infarction due to extensive vasculitis. Soon, a cerebrovascul insult developed and CT-scan revealed endocranial infarctus. The patient was treated with corticosteroids and cyclophosphamide pulses (totally VI monthly pulses), and also with low-molecular heparine, anticoagulants and salicylates because of the right leg phlebothrombosis. After the pulses, the patient was adviced to take prednisone 20 mg daily and azothioprine 100 mg daily, and 6 months later mycophenolate mofetil because of persistent active serological immunological findings (ANA 1 : 320) and nephrotic syndrome. Mycophenolate mofetil was efficient in inducing and maintaining remission of nephrotic syndrome. Conclusion. The aim of LN treatment is to achieve and maintain remission, improve patients’ outcome, reduce the toxicity of immunosuppressive drugs and the incidence of relapses. Mycophenolate mofetil was shown to be efficient in inducing and maintaining remission of nephrotic syndrome in the frame of LN.http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501108705J.pdflupus nephritisdisease progressiontreatment outcome |
| spellingShingle | Jovanović Nataša Marković-Lipkovski Jasmina Pavlović Stevan Stojimirović Biljana A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up Vojnosanitetski Pregled lupus nephritis disease progression treatment outcome |
| title | A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up |
| title_full | A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up |
| title_fullStr | A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up |
| title_full_unstemmed | A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up |
| title_short | A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up |
| title_sort | patient with systemic lupus erythematosus and lupus nephritis a 12 year follow up |
| topic | lupus nephritis disease progression treatment outcome |
| url | http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501108705J.pdf |
| work_keys_str_mv | AT jovanovicnatasa apatientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT markoviclipkovskijasmina apatientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT pavlovicstevan apatientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT stojimirovicbiljana apatientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT jovanovicnatasa patientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT markoviclipkovskijasmina patientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT pavlovicstevan patientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup AT stojimirovicbiljana patientwithsystemiclupuserythematosusandlupusnephritisa12yearfollowup |